Page last updated: 2024-09-03

n(6)-carboxymethyllysine and pravastatin

n(6)-carboxymethyllysine has been researched along with pravastatin in 1 studies

Compound Research Comparison

Studies
(n(6)-carboxymethyllysine)
Trials
(n(6)-carboxymethyllysine)
Recent Studies (post-2010)
(n(6)-carboxymethyllysine)
Studies
(pravastatin)
Trials
(pravastatin)
Recent Studies (post-2010) (pravastatin)
803443653,5751,036816

Protein Interaction Comparison

ProteinTaxonomyn(6)-carboxymethyllysine (IC50)pravastatin (IC50)
3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)0.1452
Insulin receptor Rattus norvegicus (Norway rat)0.0056
Prostaglandin G/H synthase 2Homo sapiens (human)0.0056
3-hydroxy-3-methylglutaryl-coenzyme A reductase Rattus norvegicus (Norway rat)0.0254
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)3.6

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gu, L; Ni, Z; Qian, J; Tomino, Y1

Other Studies

1 other study(ies) available for n(6)-carboxymethyllysine and pravastatin

ArticleYear
Pravastatin inhibits carboxymethyllysine-induced monocyte chemoattractant protein 1 expression in podocytes via prevention of signalling events.
    Nephron. Experimental nephrology, 2007, Volume: 106, Issue:1

    Topics: Animals; Cells, Cultured; Chemokine CCL2; Dose-Response Relationship, Drug; Drug Combinations; Gene Expression; Lysine; Mice; Podocytes; Pravastatin; Signal Transduction

2007